Key result
High-risk genotype-phenotype model linked to ~5-fold higher recurrent cardiac event risk in male LQTS adolescents.
Why the study?
Sex-specific risk management may improve outcomes in congenital long QT syndrome, prompting the development of personalized risk estimates for cardiac and life-threatening events specifically in male adolescents with potassium channel-mediated disease.
Does a genotype-phenotype risk prediction model accurately stratify the risk of cardiac and life-threatening events in male adolescents with potassium channel-mediated LQTS?
Cohort (n=611)
Yes
Does a genotype-phenotype risk prediction model accurately stratify the risk of cardiac and life-threatening events in male adolescents with potassium channel-mediated LQTS?
A personalized genotype-phenotype risk prediction model successfully stratifies male adolescents with potassium channel-mediated LQTS into low, intermediate, and high risk for recurrent cardiac events and life-threatening events.
Answers are grounded in this paper and cite their sources.
May support genotype-phenotype stratification of recurrent events in male LQTS adolescents; leaves open prospective validation before clinical use.
Background Sex‐specific risk management may improve outcomes in congenital long QT syndrome (LQTS). We recently developed a prediction score for cardiac events (CEs) and life‐threatening events (LTEs) in postadolescent women with LQTS. In the present study, we aimed to develop personalized risk estimates for the burden of CEs and LTEs in male adolescents with potassium channel‐mediated LQTS. Methods and Results The prognostic model was derived from the LQTS Registry headquartered in Rochester, NY, comprising 611 LQT1 or LQT2 male adolescents from age 10 through 20 years, using the following variables: genotype/mutation location, QTc‐specific thresholds, history of syncope, and β‐blocker therapy. Anderson‐Gill modeling was performed for the end point of CE burden (total number of syncope, aborted cardiac arrest, and appropriate defibrillator shocks). The applicability of the CE prediction model was tested for the end point of the first LTE (excluding syncope and adding sudden cardiac death) using Cox modeling. A total of 270 CEs occurred during follow‐up. The genotype–phenotype risk prediction model identified low‐, intermediate‐, and high‐risk groups, comprising 74%, 14%, and 12% of the study population, respectively. Compared with the low‐risk group, high‐risk male subjects experienced a pronounced 5.2‐fold increased risk of recurrent CEs ( P <0.001), whereas intermediate‐risk patients had a 2.1‐fold ( P =0.004) increased risk . At age 20 years, the low‐, intermediate‐, and high‐risk adolescent male patients had on average 0.3, 0.6, and 1.4 CEs per person, respectively. Corresponding 10‐year adjusted probabilities for a first LTE were 2%, 6%, and 8%. Conclusions Personalized genotype–phenotype risk estimates can be used to guide sex‐specific management in male adolescents with potassium channel‐mediated LQTS.
No takes yet. Share an insight, caveat, or question.
Bjelic et al. (2024) conducted a cohort in Congenital Long QT Syndrome (n=611). Genotype-phenotype risk prediction model (high-risk group) vs. Low-risk group was evaluated on Cardiac event burden (total number of syncope, aborted cardiac arrest, and appropriate defibrillator shocks) (HR 5.2, p=<0.001). A genotype-phenotype risk model identified high-risk male adolescents with LQTS who had a 5.2-fold increased risk of recurrent cardiac events compared to low-risk patients (P<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: